The FDA’s Center for Drug Evaluation and Research (CDER) has asked for public opinion on the barriers and aids to incorporating successful or promising innovative clinical trial approaches in drug development programs. “CDER fosters drug development by providing scientific and regulatory advice and direction,” the agency said. “This role is dynamically evolving in response to... Read More